267 related articles for article (PubMed ID: 9005983)
1. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle.
Tiao G; Hobler S; Wang JJ; Meyer TA; Luchette FA; Fischer JE; Hasselgren PO
J Clin Invest; 1997 Jan; 99(2):163-8. PubMed ID: 9005983
[TBL] [Abstract][Full Text] [Related]
2. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.
Voisin L; Breuillé D; Combaret L; Pouyet C; Taillandier D; Aurousseau E; Obled C; Attaix D
J Clin Invest; 1996 Apr; 97(7):1610-7. PubMed ID: 8601625
[TBL] [Abstract][Full Text] [Related]
3. Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism.
Hasselgren PO
Mol Biol Rep; 1999 Apr; 26(1-2):71-6. PubMed ID: 10363650
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions.
Hasselgren PO; Fischer JE
Ann Surg; 1997 Mar; 225(3):307-16. PubMed ID: 9060588
[TBL] [Abstract][Full Text] [Related]
5. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle.
Wray CJ; Sun X; Gang GI; Hasselgren PO
J Surg Res; 2002 May; 104(2):82-7. PubMed ID: 12020124
[TBL] [Abstract][Full Text] [Related]
6. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors.
Hobler SC; Tiao G; Fischer JE; Monaco J; Hasselgren PO
Am J Physiol; 1998 Jan; 274(1):R30-7. PubMed ID: 9458895
[TBL] [Abstract][Full Text] [Related]
7. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia.
Chai J; Wu Y; Sheng ZZ
Crit Care Med; 2003 Jun; 31(6):1802-7. PubMed ID: 12794423
[TBL] [Abstract][Full Text] [Related]
8. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids.
Auclair D; Garrel DR; Chaouki Zerouala A; Ferland LH
Am J Physiol; 1997 Mar; 272(3 Pt 1):C1007-16. PubMed ID: 9124503
[TBL] [Abstract][Full Text] [Related]
9. Pathways of muscle protein breakdown in injury and sepsis.
Hasselgren PO
Curr Opin Clin Nutr Metab Care; 1999 Mar; 2(2):155-60. PubMed ID: 10453347
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
Liu Z; Miers WR; Wei L; Barrett EJ
Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-proteasome-dependent proteolysis in skeletal muscle.
Attaix D; Aurousseau E; Combaret L; Kee A; Larbaud D; Rallière C; Souweine B; Taillandier D; Tilignac T
Reprod Nutr Dev; 1998; 38(2):153-65. PubMed ID: 9638789
[TBL] [Abstract][Full Text] [Related]
12. Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis.
Hobler SC; Williams A; Fischer D; Wang JJ; Sun X; Fischer JE; Monaco JJ; Hasselgren PO
Am J Physiol; 1999 Aug; 277(2):R434-40. PubMed ID: 10444550
[TBL] [Abstract][Full Text] [Related]
13. The balance between glucocorticoids and insulin regulates muscle proteolysis via the ubiquitin-proteasome pathway.
Bailey JL; Wang X; Price SR
Miner Electrolyte Metab; 1999; 25(4-6):220-3. PubMed ID: 10681643
[TBL] [Abstract][Full Text] [Related]
14. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma.
Baracos VE; DeVivo C; Hoyle DH; Goldberg AL
Am J Physiol; 1995 May; 268(5 Pt 1):E996-1006. PubMed ID: 7539218
[TBL] [Abstract][Full Text] [Related]
15. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle.
Tiao G; Fagan JM; Samuels N; James JH; Hudson K; Lieberman M; Fischer JE; Hasselgren PO
J Clin Invest; 1994 Dec; 94(6):2255-64. PubMed ID: 7989581
[TBL] [Abstract][Full Text] [Related]
16. Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats.
Combaret L; Tilignac T; Claustre A; Voisin L; Taillandier D; Obled C; Tanaka K; Attaix D
Biochem J; 2002 Jan; 361(Pt 2):185-92. PubMed ID: 11772390
[TBL] [Abstract][Full Text] [Related]
17. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.
Attaix D; Combaret L; Tilignac T; Taillandier D
Mol Biol Rep; 1999 Apr; 26(1-2):77-82. PubMed ID: 10363651
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the ubiquitin-proteasome pathway to overall muscle proteolysis in hypercatabolic patients.
Biolo G; Bosutti A; Iscra F; Toigo G; Gullo A; Guarnieri G
Metabolism; 2000 Jun; 49(6):689-91. PubMed ID: 10877190
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting.
Mitch WE; Bailey JL; Wang X; Jurkovitz C; Newby D; Price SR
Am J Physiol; 1999 May; 276(5):C1132-8. PubMed ID: 10329962
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-proteasome-dependent muscle proteolysis responds slowly to insulin release and refeeding in starved rats.
Kee AJ; Combaret L; Tilignac T; Souweine B; Aurousseau E; Dalle M; Taillandier D; Attaix D
J Physiol; 2003 Feb; 546(Pt 3):765-76. PubMed ID: 12563002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
